Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene. Issue 5 (13th January 2015)

• Record Type: Journal Article
• Authors: Sasidharan, Abhilash; Sivaram, Amal J.; Retnakumari, Archana P.; Chandran, Parwathy; Malarvizhi, Giridharan Loghanathan; Nair, Shantikumar; Koyakutty, Manzoor
• Is Part Of: Advanced healthcare materials. Volume 4:Issue 5(2015)
• Page Start: 679
• Page End: 684
• Publication Date: 2015-01-13
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/adhm.201400670
• Languages: English
• ISSNs: 2192-2640

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="adhm201400670-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>Under ultralow radiofrequency (RF) power</bold>, transferrin‐conjugated graphene nanoparticles can thermally ablate drug‐ or radiation‐resistant cancer cells very effectively. The results suggest that graphene‐based RF hyperthermia can be an efficient method to manage drug‐/radiation‐resistant cancers. <boxed-text content-type="graphic" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgjg5cfxcf" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>